Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bronchiectasis

• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis
• Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations
• Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
• A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)
• ClairleafTM: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
• Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
• A Study of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
• Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
• Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-CF Bronchiectasis With Excess Mucus and Cough
• Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
• Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults
• A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis
• Bronchodilators on the Exercise Capacity of Bronchiectasis Patients
• COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
• Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.
• Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations
• A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
• Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)
• RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
• A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method
• A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis
• Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis
• Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation
• The Role of Vitamin D3 in Pediatric Bronchiectasis Severity
• Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
• Roflumilast in Non-CF Bronchiectasis Study (2019)
• Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis
• Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)
• Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis
• Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis
• Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis
• A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis
• Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis
• Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention
• Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
• Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial
• Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
• The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases
• Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis
• Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
• Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
• Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium (PROMIS II)
• Effects of Traditional Chinese Medicine on Bronchiectasis Patients
• Roflumilast in Non-CF Bronchiectasis Study
• Inhaled A1AT in Adult Stable Bronchiectasis
• Assessment of INS1007 in Subjects With Non-Cystic Fibrosis Bronchiectasis
• Long Term Efficacy and Safety of Inhaled Colistimethate Sodium in Bronchiectasis Subjects With Chronic Pseudomonas Aeruginosa Infection.
• A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects
• Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
• Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
• Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis
• Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection
• Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
• Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis
• Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients
• Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
• The Efficacy of Azithromycin in Treating Children With Non Cystic Fibrosis Bronchiectasis
• Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis
• Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis
• Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa
• Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
• Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis
• Efficacy of Azithromycin in Treatment of Bronchiectasis
• Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
• Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)
• Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
• Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
• Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis
• Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
• Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
• Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
• Prevention of OM-85 on Bronchiectasis Exacerbation
• Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis
• The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
• Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
• Bacteriology and Inflammation in Bronchiectasis
• The Effect of Theophylline in the Treatment of Bronchiectasis
• A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
• Phase2, Single Group, Open Clinical Trial to Evaluate the Efficacy and Safety of Roflumilast in Symptomatic Bronchiectasis Patients
• Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)
• Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis
• Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
• Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
• Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa
• A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
• Prevention of Bronchiectasis in Infants With Cystic Fibrosis
• Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis
• A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
• High Dose Inhaled Mannitol Study
• Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis
• Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"
• Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis
• Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
• A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis
• Long Term Nebulised Gentamicin in Patients With Bronchiectasis
• A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
• Efficacy of Budesonide-Formoterol in Bronchiectasis
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis
• Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
• The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis
• Bronchiectasis and Long Term Azithromycin Treatment
• Safety and Efficacy of Bronchitol in Bronchiectasis